Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 1,277 | 1,076 | 1,348 | 2,739 | 3,136 |
| Cost of Goods | 277 | -58 | 85 | 252 | -5,847 |
| Gross Profit | 1,000 | 1,134 | 1,263 | 2,487 | 8,983 |
| Operating Expenses | 14,789 | 6,487 | 13,400 | 17,659 | 15,270 |
| Operating Income | -13,512 | -5,411 | -12,052 | -14,920 | -7,134 |
| Interest Expense | 2,410 | 2,083 | 2,009 | 2,257 | 2,218 |
| Other Income | 1,313 | -5,652 | 286 | 413 | 689 |
| Pre-tax Income | -14,609 | -13,146 | -13,775 | -16,764 | -8,663 |
| Income Tax | 0 | N/A | -92 | 2 | 2 |
| Net Income Continuous | -14,609 | -13,146 | -13,683 | -16,766 | -8,665 |
| Net Income Discontinuous | 389 | 213,782 | 6,080 | 21,405 | 26,647 |
| Net Income | $-14,220 | $200,636 | $-7,603 | $4,639 | $17,982 |
| EPS Basic Total Ops | -3.61 | 49.61 | -1.88 | 1.25 | 4.50 |
| EPS Basic Continuous Ops | -3.77 | -3.25 | -3.38 | -4.00 | -2.21 |
| EPS Basic Discontinuous Ops | 0.16 | 52.86 | 1.50 | 5.25 | 6.71 |
| EPS Diluted Total Ops | -3.61 | 49.61 | -1.88 | 1.25 | 4.50 |
| EPS Diluted Continuous Ops | -3.77 | -3.25 | -3.38 | -4.00 | -2.21 |
| EPS Diluted Discontinuous Ops | 0.16 | 52.86 | 1.50 | 5.25 | 6.71 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.61 | -3.38 | -4.00 | -2.00 |
| EBITDA(a) | $-13,577 | $-5,217 | $-11,831 | $-14,594 | $-6,782 |